Indaptus Therapeutics, Inc. — Director's Dealing 2023

Jan 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2023-01-18

Reporting Person: Meckler Jeffrey A (Director, CEO and Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-18	Stock Option (Right to Buy)	$1.61	A	100000	Acquired	2033-01-18	Common Stock (100000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026.